Die Wiener Skyline bei Nacht. Die Stadt ist der wichtigste Finanzplatz Österreichs.
Quelle: - pixabay.com:
Google
PR Newswire  | 

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX, RNA, ATXS, and FSUN

PR Newswire

play Anhören
share Teilen
feedback Feedback
copy Kopieren
newsletter
font_big Schrift vergrößern
Astria Therapeutics Inc 12,94 $ Astria Therapeutics Inc Chart -1,37%
Zugehörige Wertpapiere:
Avidity Biosciences 71,73 $ Avidity Biosciences Chart +0,27%
Zugehörige Wertpapiere:
Firstsun CAP Bancorp COM 35,92 $ Firstsun CAP Bancorp COM Chart +2,39%
Zugehörige Wertpapiere:
THIRD COAST BANCSH. 38,45 $ THIRD COAST BANCSH. Chart -1,31%
Zugehörige Wertpapiere:

NEW YORK, Dec. 1, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating

  • Third Coast Bancshares, Inc. (NYSE: TCBX) related to its merger with Keystone Bancshares, Inc. Under the terms of the proposed transaction, Keystone shareholders will receive either (i) 0.45925 shares of Third Coast common stock or (ii) an amount of cash equal to 0.45925 mulaviditiplied by the volume-weighted average price per share of Third Coast common stock for the 20 trading day period set forth in the merger agreement, at the election of Keystone's shareholders.

Click here for more information https://monteverdelaw.com/case/third-coast-bancshares-inc/. It is free and there is no cost or obligation to you.

  • Avidity Biosciences, Inc. (NASDAQ: RNA) related to its sale to Novartis AG. Under the terms of the proposed transaction, Avidity shareholders will receive $72.00 per share in cash.

Click here for more information https://monteverdelaw.com/case/avidity-biosciences-inc/. It is free and there is no cost or obligation to you.

  • Astria Therapeutics, Inc. (NASDAQ: ATXS) related to its sale to BioCryst Pharmaceuticals, Inc. Under the terms of the proposed transaction, Astria shareholders will receive $8.55 in cash per share and 0.59 shares of BioCryst common stock per Astria share.

Click here for more information https://monteverdelaw.com/case/astria-therapeutics-inc/. It is free and there is no cost or obligation to you.

  • FirstSun Capital Bancorp (NASDAQ: FSUN) related to its merger with First Foundation Inc. Upon completion of the proposed transaction, FirstSun shareholders will own 59.5% of the combined company.

Click here for more info https://monteverdelaw.com/case/firstsun-capital-bancorp/. It is free and there is no cost or obligation to you.

Monteverde & Associates PC Logo

NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:

  1. Do you file class actions and go to Court?
  2. When was the last time you recovered money for shareholders?
  3. What cases did you recover money in and how much?

About Monteverde & Associates PC

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/hareholder-alert-the-ma-class-action-firm-launches-legal-inquiry-for-the-mergertcbx-rna-atxs-and-fsun-302629417.html

SOURCE Monteverde & Associates PC


Für dich aus unserer Redaktion zusammengestellt

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Weitere Artikel des Autors

Themen im Trend